Catalyst Wire Dossier Catalyst Wire Dossier

Dabigatran etexilate (generic)

Dabigatran etexilate · XLCare Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Dabigatran etexilate (generic), covering 2024-08-13 to 2024-08-13. Get the full timeline:

Most recent: FDA Approved: DABIGATRAN ETEXILATE — Original Application (XLCare Pharmaceuticals, Inc.)

See pricing